Welcome to LookChem.com Sign In|Join Free
  • or
N-cyclohexyl-4-phenoxybenzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

306764-75-0

Post Buying Request

306764-75-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

306764-75-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 306764-75-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,6,7,6 and 4 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 306764-75:
(8*3)+(7*0)+(6*6)+(5*7)+(4*6)+(3*4)+(2*7)+(1*5)=150
150 % 10 = 0
So 306764-75-0 is a valid CAS Registry Number.

306764-75-0Downstream Products

306764-75-0Relevant academic research and scientific papers

Design, synthesis, and structure-activity relationship studies of novel diaryl ether amides as potential antitumor agents

Zheng, Man-Yi,Huang, Zhi-Ning,Yang, Shao-Mei,Han-Liang,Lu-Xu,Wang, Bao-Rui,Wang, Li-Juan,Wang, Hai-Li,Li, Shan-Hua,Li, Fu-Nan

, p. 727 - 736 (2019/05/22)

Sorafenib is a drug that has been verified to be effective on hepatoma cells. Three series of diaryl ethers have been designed and synthesized based on the structure of sorafenib. The 5m compound shows better inhibitory potency against HepG2 cells (IC50 = 1.96 μM) than sorafenib (IC50 = 9.61μM). These results have been verified with MTT assay and colony-forming assay. Moreover, compound 5m exhibits good antitumor activities against PLC/PRF5, HeLa, A549, and HT-29 cell lines. The excellent bioactivity of compound 5m confirms that a single optical conformation is superior to the racemate. A western blotting analysis indicates that compound 5m induces the apoptosis of HepG2 cells by enhancing the protein levels of p21 and Cl-caspase3.

Structure-based design, structure-activity relationship analysis, and antitumor activity of diaryl ether derivatives

Yang, Shao-Mei,Huang, Zhi-Ning,Zhou, Zhong-Shi,Hou, Jin,Zheng, Man-Yi,Wang, Li-Juan,Jiang, Yu,Zhou, Xin-Yi,Chen, Qiu-Yue,Li, Shan-Hua,Li, Fu-Nan

, p. 1761 - 1773 (2015/03/14)

To identify novel therapeutic agents to treat cancer, we synthesized a series of diaryl ether derivatives. Structure-activity relationship studies revealed that the presence of a chlorine or hydroxyl at the para-position on the phenyl ring (5h or 5k) significantly enhanced antitumor activity. Compound 5h had stronger growth inhibitory activity in HepG2, A549, and HT-29 cells than compound 5k, with IC50 values of 2.57, 5.48, and 30.04 μM, respectively. Compound 5h also inhibited the growth of other cells lines, including Hep3B, PLC/PRF5, SMMC-7721, HeLa, and A375, with IC50 values of 2.76, 4.26, 29.66, 18.86, and 10.21 μM, respectively. The antitumor activity of compound 5h was confirmed by a colony forming assay. Further, our results indicated that the antitumor activity of compound 5h may be mediated by enhancing expression of p21 and cl-caspase3, and leading to apoptosis of cancer cells.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 306764-75-0